Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (unaudited) - USD ($) $ in Thousands |
Total |
IPO |
Series A Redeemable Convertible Preferred Stock |
Series A Redeemable Convertible Preferred Stock
IPO
|
Series B Redeemable Convertible Preferred Stock |
Series B Redeemable Convertible Preferred Stock
IPO
|
Common Stock |
Common Stock
IPO
|
Common Stock
License Agreement with Stanford
|
Additional Paid in Capital |
Additional Paid in Capital
IPO
|
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Beginning balance at Dec. 31, 2020 |
$ (65,408)
|
|
|
|
|
|
|
|
|
$ 5,183
|
|
|
$ (70,591)
|
Temporary equity, Beginning balance, Shares at Dec. 31, 2020 |
|
|
30,019,945
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, Beginning balance at Dec. 31, 2020 |
|
|
$ 55,608
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
|
|
|
|
|
|
10,279,102
|
|
|
|
|
|
|
Issuance of redeemable convertible preferred stock for cash |
|
|
$ 14,997
|
|
$ 150,524
|
|
|
|
|
|
|
|
|
Issuance of redeemable convertible preferred stock for cash, Shares |
|
|
15,000,000
|
|
29,792,487
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
1,033
|
|
|
|
|
|
|
|
|
1,033
|
|
|
|
Common stock issued upon exercise of options, shares |
|
|
|
|
|
|
918,825
|
|
|
|
|
|
|
Vesting of early exercised stock options |
7
|
|
|
|
|
|
|
|
|
7
|
|
|
|
Reclassification of tranche liability upon settlement |
|
|
$ 39,403
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(19,709)
|
|
|
|
|
|
|
|
|
|
|
|
(19,709)
|
Ending balance at Mar. 31, 2021 |
(84,077)
|
|
|
|
|
|
|
|
|
6,223
|
|
|
(90,300)
|
Temporary equity, Ending balance, Shares at Mar. 31, 2021 |
|
|
45,019,945
|
|
29,792,487
|
|
|
|
|
|
|
|
|
Temporary equity, Ending balance at Mar. 31, 2021 |
|
|
$ 110,008
|
|
$ 150,524
|
|
|
|
|
|
|
|
|
Ending balance, Shares at Mar. 31, 2021 |
|
|
|
|
|
|
11,197,927
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
(65,408)
|
|
|
|
|
|
|
|
|
5,183
|
|
|
(70,591)
|
Temporary equity, Beginning balance, Shares at Dec. 31, 2020 |
|
|
30,019,945
|
|
|
|
|
|
|
|
|
|
|
Temporary equity, Beginning balance at Dec. 31, 2020 |
|
|
$ 55,608
|
|
|
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
|
|
|
|
|
|
10,279,102
|
|
|
|
|
|
|
Net loss and comprehensive loss |
$ (37,238)
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock issued upon exercise of options, shares |
922,208
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
$ (37,238)
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2021 |
379,184
|
|
|
|
|
|
$ 1
|
|
|
487,012
|
|
|
(107,829)
|
Ending balance, Shares at Jun. 30, 2021 |
|
|
|
|
|
|
55,979,002
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2021 |
(84,077)
|
|
|
|
|
|
|
|
|
6,223
|
|
|
(90,300)
|
Temporary equity, Beginning balance, Shares at Mar. 31, 2021 |
|
|
45,019,945
|
|
29,792,487
|
|
|
|
|
|
|
|
|
Temporary equity, Beginning balance at Mar. 31, 2021 |
|
|
$ 110,008
|
|
$ 150,524
|
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2021 |
|
|
|
|
|
|
11,197,927
|
|
|
|
|
|
|
Stock-based compensation expense |
2,018
|
|
|
|
|
|
|
|
|
2,018
|
|
|
|
Net loss and comprehensive loss |
(17,529)
|
|
|
|
|
|
|
|
|
|
|
|
(17,529)
|
Common stock shares issued upon early exercise of options |
$ 21
|
|
|
|
|
|
|
|
|
21
|
|
|
|
Common stock issued upon exercise of options, shares |
3,383
|
|
|
|
|
|
3,383
|
|
|
|
|
|
|
Issuance of common stock |
|
$ 218,177
|
|
|
|
|
|
|
|
|
$ 218,177
|
|
|
Issuance of common stock, Shares |
|
|
|
|
|
|
|
14,000,000
|
640,861
|
|
|
|
|
Repurchase of common shares in connection with terms of License Agreement with Stanford |
|
|
|
|
|
|
|
|
(624,845)
|
|
|
|
|
Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering |
|
$ 260,532
|
|
|
|
|
|
$ 1
|
|
|
$ 260,531
|
|
|
Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering |
|
|
|
(45,019,945)
|
|
(29,792,487)
|
|
|
|
|
|
|
|
Temporary equity, Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering |
|
|
|
$ (110,008)
|
|
$ (150,524)
|
|
|
|
|
|
|
|
Conversion of redeemable convertible preferred stock to common stock at closing of initial public offering, Shares |
|
|
|
|
|
|
|
30,761,676
|
|
|
|
|
|
Vesting of early exercised stock options |
$ 42
|
|
|
|
|
|
|
|
|
42
|
|
|
|
Net loss |
(17,529)
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2021 |
379,184
|
|
|
|
|
|
$ 1
|
|
|
487,012
|
|
|
(107,829)
|
Ending balance, Shares at Jun. 30, 2021 |
|
|
|
|
|
|
55,979,002
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
384,050
|
|
|
|
|
|
$ 1
|
|
|
525,400
|
|
|
(141,351)
|
Beginning balance at Dec. 31, 2021 |
|
|
|
|
|
|
58,010,823
|
|
|
|
|
|
|
Stock-based compensation expense |
3,342
|
|
|
|
|
|
|
|
|
3,342
|
|
|
|
Vesting of early exercised stock options |
51
|
|
|
|
|
|
|
|
|
51
|
|
|
|
Unrealized loss on investment |
(309)
|
|
|
|
|
|
|
|
|
|
|
$ (309)
|
|
Net loss |
(25,835)
|
|
|
|
|
|
|
|
|
|
|
|
(25,835)
|
Ending balance at Mar. 31, 2022 |
361,299
|
|
|
|
|
|
$ 1
|
|
|
528,793
|
|
(309)
|
(167,186)
|
Ending balance, Shares at Mar. 31, 2022 |
|
|
|
|
|
|
58,010,823
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
384,050
|
|
|
|
|
|
$ 1
|
|
|
525,400
|
|
|
(141,351)
|
Beginning balance at Dec. 31, 2021 |
|
|
|
|
|
|
58,010,823
|
|
|
|
|
|
|
Net loss and comprehensive loss |
(52,804)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(51,771)
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
338,456
|
|
|
|
|
|
$ 1
|
|
|
532,610
|
|
(1,033)
|
(193,122)
|
Ending balance, Shares at Jun. 30, 2022 |
|
|
|
|
|
|
58,211,192
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2022 |
361,299
|
|
|
|
|
|
$ 1
|
|
|
528,793
|
|
(309)
|
(167,186)
|
Beginning balance at Mar. 31, 2022 |
|
|
|
|
|
|
58,010,823
|
|
|
|
|
|
|
Stock-based compensation expense |
3,360
|
|
|
|
|
|
|
|
|
3,360
|
|
|
|
Net loss and comprehensive loss |
(26,660)
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock shares issued upon early exercise of options |
13
|
|
|
|
|
|
|
|
|
13
|
|
|
|
Common stock issued upon exercise of options, shares |
|
|
|
|
|
|
43,945
|
|
|
|
|
|
|
Common stock issued under ESPP, Shares |
|
|
|
|
|
|
207,137
|
|
|
|
|
|
|
Common stock issued under ESPP |
414
|
|
|
|
|
|
|
|
|
414
|
|
|
|
Vesting of early exercised stock options |
30
|
|
|
|
|
|
|
|
|
30
|
|
|
|
Repurchase of unvested early exercised stock options, Shares |
|
|
|
|
|
|
(50,713)
|
|
|
|
|
|
|
Repurchase of unvested early exercised stock options, Value |
0
|
|
|
|
|
|
|
|
|
0
|
|
|
|
Unrealized loss on investment |
(724)
|
|
|
|
|
|
|
|
|
|
|
(724)
|
|
Net loss |
(25,936)
|
|
|
|
|
|
|
|
|
|
|
|
(25,936)
|
Ending balance at Jun. 30, 2022 |
$ 338,456
|
|
|
|
|
|
$ 1
|
|
|
$ 532,610
|
|
$ (1,033)
|
$ (193,122)
|
Ending balance, Shares at Jun. 30, 2022 |
|
|
|
|
|
|
58,211,192
|
|
|
|
|
|
|